ALT vs CCI · rev $20.0K vs P/E 40, rev $6.57B
Altimmune Inc (ALT) versus Crown Castle (CCI) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Crown Castle (CCI) is a reit - specialty company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
ALT currently screens at market cap $527.0M. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Not investment advice. Open the ALT and CCI stock pages for the full models.
Not investment advice.